Depression and T-lymphocyte count decreased

Summary:

T-lymphocyte count decreased is found among people with Depression, especially for people who are male, 50-59 old.

The study analyzes which people have T-lymphocyte count decreased with Depression. It is created by eHealthMe based on reports of 15 people who have Depression from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Depression?

Depression is found to be associated with 3,168 drugs and 4,126 conditions by eHealthMe. Check the latest studies of Depression.

What is T-lymphocyte count decreased?

T-lymphocyte count decreased is found to be associated with 124 drugs and 201 conditions by eHealthMe. Check the latest studies of T-lymphocyte count decreased.

On Jul, 26, 2026

15 people who have Depression and T-Lymphocyte Count Decreased are studied.

Would you have T-lymphocyte count decreased when you have Depression?

Gender of people who have Depression and experienced T-Lymphocyte Count Decreased *:

female: 35.71 %
male: 64.29 %

Age of people who have Depression and experienced T-Lymphocyte Count Decreased *:

Common co-existing conditions for these people *:

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 53.33%
Muscle Spasms (muscle contraction): 5 people, 33.33%
High Blood Cholesterol: 4 people, 26.67%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 26.67%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 20.00%
Pain: 3 people, 20.00%
Sleep Disorder: 3 people, 20.00%
Stress And Anxiety: 3 people, 20.00%
Rashes (redness): 2 people, 13.33%

Common drugs taken by these people *:

Common symptoms for these people *:

Fatigue (feeling of tiredness): 9 people, 60.00%
Weakness: 8 people, 53.33%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 40.00%
White Blood Cell Count Decreased: 5 people, 33.33%
Speech Impairment (Adult) (inability to speak (adult)): 5 people, 33.33%
Chills (felling of cold): 5 people, 33.33%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 33.33%
Cd4 Lymphocytes Decreased: 5 people, 33.33%
Lymphocyte Count Decreased: 5 people, 33.33%
Confusional State: 5 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have T-lymphocyte count decreased?

- Check whether T-lymphocyte count decreased is associated with a drug or a condition

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on T-lymphocyte count decreased and Depression, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.